12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Veloxis Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00664859
First received: April 21, 2008
Last updated: December 18, 2014
Last verified: October 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2009
  Primary Completion Date: February 2009 (Final data collection date for primary outcome measure)